Repligen Corporation
Repligen | Inspiring advances in bioprocessing
Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide.
Repligen Corporation | LinkedIn
Repligen Corporation | 33140 followers on LinkedIn. FRAUD ALERT: Please take note that it has come to our attention that individuals purporting to work for ...
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs.
Repligen Corporation (RGEN) - Yahoo Finance
Repligen Corporation Overview Medical Instruments & Supplies / Healthcare · Repligen Earnings: Exceeds Expectations, Recovery Well Under Way · Raising target ...
Repligen Corporation to Present at Upcoming Investor Conferences. 11/5/2024 ... Repligen Corporation to Present at Wells Fargo Healthcare Conference. 8 ...
Repligen Corp Company Profile - GlobalData
Repligen Corp (Repligen) operates as a bioprocessing life science company that develops and commercializes consumable products for manufacturing biological ...
Repligen Corporation - AnnualReports.com
Repligen Corporation ... Repligen Corporation (NASDAQ:RGEN) is a bioprocessing company focused on the development, manufacture and commercialization of highly ...
Repligen Corporation | Careers Center | Welcome
Welcome to the Careers Center for Repligen Corporation. Please browse all of our available job and career opportunities. Apply to any positions you believe ...
Repligen Corporation - ResponsibilityReports.com
Most Recent Responsibility Report ... Repligen Corporation does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to ...
Repligen Corporation - GlobeNewswire
Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2024 financial results on Wednesday, May 1, 2024.
Repligen Corporation's Earnings Preview: Expensive With Mixed ...
Repligen Corporation is a bioprocessing technology company focusing on process intensification, purification, and fluid management, ...
Investor Presentations and Events - Press Releases | Repligen - Q4
Repligen Investor Presentation - Repligen Corporation Announces Agreement to Acquire Metenova AB ... © Copyright 2024 Repligen Corporation. All rights ...
Repligen - Crunchbase Company Profile & Funding
Repligen Corporation is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of ...
Repligen Corporation Common Stock (RGEN) - Nasdaq
Discover real-time Repligen Corporation Common Stock (RGEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment ...
Repligen Announces Agreement to Acquire Avitide, Inc.
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase ...
Repligen Corporation - MassBio
Overview. Repligen Corporation (NASDAQ:RGEN) is a life sciences company focused on the development and commercialization of high-value consumable products used ...
Repligen Corporation to Present at Upcoming Investor Conferences
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems ...
Working at RepliGen Corporation: 49 Reviews - Indeed
Overall, not a bad experience in terms of workload and company culture. The company definitely loves to rides its "highs" when profits are coming in, but the ...
Repligen Corp - Company Profile and News - Bloomberg Markets
Company profile page for Repligen Corp including stock price, company news, executives, board members, and contact information.
RGEN Stock Price Quote | Morningstar
See the latest Repligen Corp stock price (RGEN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.